Status:

COMPLETED

Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve

Lead Sponsor:

Ottawa Heart Institute Research Corporation

Collaborating Sponsors:

GE Healthcare

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Brief Summary

Patients will be recruited from those referred to the local site's Diagnostic Imaging Department for SPECT myocardial perfusion imaging (MPI) ,who have an intermediate to high pre-test likelihood of d...

Detailed Description

Patients will be recruited from those referred to the local site's Diagnostic Imaging Department for SPECT myocardial perfusion imaging (MPI), who have an intermediate to high pre-test likelihood of d...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years old
  • BMI ≤ 40 kg/m2
  • Able and willing to comply with the study procedures
  • Written informed consent
  • Intermediate to high probability of CAD
  • Suspected or known CAD on a stable medication regime

Exclusion

  • History or risk of severe bradycardia (heart rate \< 50 beats per minute) not related to chronotropic drugs
  • Known second- or third-degree AV block without pacemaker
  • Dyspnea (NYHA III/IV), wheezing asthma or COPD
  • Coronary artery bypass graft (CABG) surgery within 60 days prior to screening or within 45 days after consent (early revascularization)
  • Percutaneous coronary intervention (PCI) within 30 days prior to screening or within 45 days following consent (early revascularization)
  • Recent use of dipyridamole, dipyridamole-containing medications (e.g. Aggrenox)
  • Known hypersensitivity to dipyridamole or adenosine
  • Breastfeeding or pregnancy
  • Claustrophobia or inability to lie still in a supine position
  • Unwillingness or inability to provide informed consent

Key Trial Info

Start Date :

October 12 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2022

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT03427749

Start Date

October 12 2018

End Date

October 1 2022

Last Update

April 10 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Universitaire ziekenhuizen Leuven

Leuven, Belgium

2

London Health Sciences Centre

London, Ontario, Canada

3

University of Ottawa Heart Institute

Ottawa, Ontario, Canada, K1Y 4W7

4

Medizinische Hochschule Hannover

Hanover, Germany